Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Form 8.3 - [FFastFill PLC]

12 Mar 2013 16:56

RNS Number : 8490Z
Maven Income and Growth VCT 5 PLC
12 March 2013
Ā 

FORM 8.3

Ā 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Ā 

1. KEY INFORMATION

Ā 

(a) Identity of the person whose positions/dealings are being disclosed:

Maven Income and Growth VCT 5 PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FFastfill Plc Ordinary 1p Shares

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

11 March 2013

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

Ā 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Ā 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Ā 

Class of relevant security:

Ā 

1p Ordinary Shares

Ā 

Ā 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,082,318

0.22

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

Ā 

TOTAL:

1,082,318

0.22

Ā 

All interests and all short positions should be disclosed.

Ā 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Ā 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Ā 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Ā 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Ā 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Ā 

(a) Purchases and sales

Ā 

Class of relevant security

Purchase/sale

Ā 

Number of securities

Price per unit

Ā 

Ā 

Ā 

(b) Derivatives transactions (other than options)

Ā 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ā 

Ā 

Ā 

(c) Options transactions in respect of existing securities

Ā 

(i) Writing, selling, purchasing or varying

Ā 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Ā 

(ii) Exercising

Ā 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Ā 

Ā 

Ā 

(d) Other dealings (including subscribing for new securities)

Ā 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Ā 

Ā 

Ā 

The currency of all prices and other monetary amounts should be stated.

Ā 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Ā 

4. OTHER INFORMATION

Ā 

(a) Indemnity and other dealing arrangements

Ā 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Ā 

None

Ā 

Ā 

(b) Agreements, arrangements or understandings relating to options or derivatives

Ā 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Ā 

None

Ā 

Ā 

(c) Attachments

Ā 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Ā 

Ā 

Date of disclosure:

11 March 2013

Contact name:

Graeme Cullen

Telephone number:

0141 206 0110

Ā 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Ā 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RETSFIFMEFDSEID
Date   Source Headline
27th Aug 201312:40 pmRNSNet Asset Value(s)
23rd Aug 201312:30 pmRNSNet Asset Value(s)
22nd Aug 201311:11 amRNSNet Asset Value(s)
21st Aug 201311:15 amRNSNet Asset Value(s)
20th Aug 201310:36 amRNSNet Asset Value(s)
19th Aug 201311:17 amRNSNet Asset Value(s)
16th Aug 201310:58 amRNSNet Asset Value(s)
15th Aug 201312:24 pmRNSNet Asset Value(s)
14th Aug 201312:54 pmRNSNet Asset Value(s)
13th Aug 201311:50 amRNSNet Asset Value(s)
12th Aug 201312:48 pmRNSNet Asset Value(s)
9th Aug 201312:03 pmRNSNet Asset Value(s)
8th Aug 20132:00 pmRNSNet Asset Value(s)
7th Aug 20134:05 pmRNSNet Asset Value(s)
6th Aug 201310:50 amRNSNet Asset Value(s)
5th Aug 201312:18 pmRNSNet Asset Value(s)
2nd Aug 201312:39 pmRNSNet Asset Value(s)
1st Aug 201311:14 amRNSNet Asset Value(s)
31st Jul 201311:56 amRNSNet Asset Value(s)
30th Jul 201311:27 amRNSNet Asset Value(s)
29th Jul 20131:38 pmRNSNet Asset Value(s)
26th Jul 20132:27 pmRNSDirector/PDMR Shareholding
26th Jul 20131:01 pmRNSNet Asset Value(s)
26th Jul 201311:26 amRNSDirector/PDMR Shareholding
26th Jul 20137:00 amRNSHalf Yearly Report
25th Jul 201310:47 amRNSNet Asset Value(s)
24th Jul 201310:50 amRNSNet Asset Value(s)
23rd Jul 201311:51 amRNSNet Asset Value(s)
22nd Jul 201310:29 amRNSNet Asset Value(s)
19th Jul 201311:13 amRNSNet Asset Value(s)
18th Jul 201312:00 pmRNSNet Asset Value(s)
17th Jul 201311:35 amRNSNet Asset Value(s)
16th Jul 201311:13 amRNSNet Asset Value(s)
15th Jul 201312:46 pmRNSNet Asset Value(s)
12th Jul 201311:11 amRNSNet Asset Value(s)
11th Jul 201310:55 amRNSNet Asset Value(s)
10th Jul 201311:20 amRNSNet Asset Value(s)
9th Jul 201311:07 amRNSNet Asset Value(s)
8th Jul 201311:04 amRNSNet Asset Value(s)
5th Jul 201310:23 amRNSNet Asset Value(s)
4th Jul 201312:25 pmRNSNet Asset Value(s)
3rd Jul 201311:04 amRNSNet Asset Value(s)
2nd Jul 201311:06 amRNSNet Asset Value(s)
1st Jul 201311:38 amRNSNet Asset Value(s)
28th Jun 201311:26 amRNSNet Asset Value(s)
27th Jun 201310:44 amRNSNet Asset Value(s)
26th Jun 201312:32 pmRNSNet Asset Value(s)
25th Jun 201310:51 amRNSNet Asset Value(s)
24th Jun 201311:50 amRNSNet Asset Value(s)
21st Jun 201312:28 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.